Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine is associated with a decrease in HBV-DNA by PCR
β Scribed by P. Honkoop; R.A. de Man; P.E. Zondervan; H.G.M. Niesters; S.W. Schalm
- Book ID
- 116121411
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 134 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0300-2977
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in
## Abstract This retrospective study investigated and characterized the YMDD motif of the hepatitis B virus (HBV) reverse transcriptase (RT) gene, in sequential samples of 17 South African patients with chronic hepatitis B infection on lamivudine treatment. The profile of HBV genotypes as well as t
## Abstract Lamivudine therapy often causes breakthrough of hepatitis B virus (HBV) DNA and breakthrough hepatitis. The aim of this study was to determine the viral factors that relate to HBVβDNA breakthrough with and without breakthrough hepatitis. Among 82 patients with chronic hepatitis B (CHB)